Only a few million doses will be shipped in the days immediately after authorization, though production will ramp up in coming weeks, with 20 million doses to be delivered by the end of March and 100...

New data appears to show the incidence has increased since April, although the problem is still rare. About nine deaths related to the issue have also been confirmed.

Now a Republican candidate for the U.S. Senate in Pennsylvania, Oz has made his medical background and his popular TV show a centerpiece of his campaign

Americans have growing concerns about how the House-passed health-care bill, if adopted by the Senate, might affect their costs.

‘I wouldn’t want to be in his position,’ says a former colleague of the FDA scientist.

The president returns to the White House at a fraught moment in his recovery.

The cancer death rate in 2017 posted the largest single-year drop ever recorded, as continued declines in smoking and new treatments reduced the lung cancer mortality rate, according to a new report...

The approval of Aduhelm set off a firestorm, with critics saying the medication doesn't work and accusing the agency of getting too close to the company.

The shots are expected to be available right after Labor Day.

Roughly 100 scientists will analyze data and communicate policy options to decision-makers and the public about how the virus is behaving and who is most at risk — in user-friendly terms.

The FDA is expected to say it will work on a proposal to lower nicotine to minimally or nonaddictive levels.

The Biden administration brokered the arrangement amid concerns about Johnson & Johnson's production delays.

The shot would be the first for children 6 months to 5 years old.

Beginning May 12, manufacturers must prove their products benefit public health. Anti-tobacco groups hail the effort, but small companies see it as a threat.

The Republican health-care bill and proposed NIH cuts have researchers buzzing at the American Society of Clinical Oncology meeting.

The agency also cleared booster shots for children 5 to 11 with compromised immune systems.

It's a public imaging makeover for his health care record.

President Trump is lashing out at the Food and Drug Administration following a disclosure Monday that an experimental coronavirus vaccine from pharmaceutical giant Pfizer is more than 90 percent...

Advocates demand action against a product that has increased illnesses and death in Black communities.

A deep dive into several large databases containing covid vaccine records has failed to confirm the preliminary information, according to the CDC and FDA.

With his voice silenced and body ravaged, Rahul Desikan's research gives him 'reason to live.'

Immunotherapy can cause reactions that mimic other disorders, leading to dangerous misdiagnoses.

Washington Post National Health Reporter Lena Sun shares her early experiences covering the pandemic and looks ahead to what we can expect next.

Aggressive marketing of the tests could confuse those clamoring for the products to determine who may have disease-fighting antibodies.

With his voice silenced and body ravaged, Rahul Desikan's research gives him 'reason to live.'

The action has been urgently sought by tobacco opponents and civil rights groups who say African Americans have been disproportionately hurt by the industry’s aggressive targeting of Black communit...

For years, doctors and patients thought there was little to do when dementia was diagnosed, even at an early stage. Now, potentially sweeping changes loom.

Medical boards received more than 480 complaints related to covid misinformation. A Washington Post investigation found at least 20 doctors have been punished.

The new president spent much of his first day in office signing orders, staffing up departments and laying plans for the days ahead.

The childhood blindness treatment marks the start of a new era as the gene-therapy field rapidly expands.

Current guidelines are too restrictive and may be missing people with mutations that could affect prevention and treatment, the surgeons group says.

Internal conflicts over whether — and when — to approve boosters are part of a tumultuous season with few parallels for the federal agency.

The action to ban menthol cigarettes was hailed by leading health and civil rights groups that have complained that the decades-long targeting of Black communities by the tobacco industry has caused...

Plan would make coronavirus shots available to millions more amid rising cases and hospitalizations.

For many parents and pediatricians, the Food and Drug Administration clearing of two vaccines comes as a huge relief.

As states try to speed rollout of coronavirus vaccines by adding people 65 and older to near the front of the line, front-line essential workers, who often face the highest risk of exposure to the...

Officials hope the signoff injects new urgency about the importance of the shots for all adults.

With $15.6 billion in coronavirus aid stripped from a deal to fund the government, Democrats are scrambling for how to fund the effort.

The vice president touts the ‘Genomic Data Commons’ as crucial to improved treatments.

Millions of machines used to treat the sleep condition have been recalled.

An advisory panel next week plans to focus on the 2 to 4 percent of U.S. adults who have suppressed immunity, a population that includes organ transplant recipients, people on cancer treatments and...

The session, which will be public, could add clarity and transparency to a decision-making process that some people have criticized as confusing.

The agency's oncology staff will work closely with physicians seeking treatments through the FDA's "expanded access" program.

The treatment, which contains a bounty of disease-fighting antibodies, could expand doctors’ repertoire for fighting the increasingly dominant variant that resists many treatments.

Monica Bertagnolli learned just before Thanksgiving she had early-stage breast cancer, which is considered treatable and has a high survival rate.

Her doctors told her there was nothing more they could do. Then Stefanie Joho connected with a small, and pivotal, clinical trial.

‘It’s so hurtful that no one is taking a stand’ on a deadly product long targeted at black communities, says health advocate.

Up to 90 percent of people with the genetic condition develop Alzheimer’s disease.

It is the first drug cleared that is designed to alter the course of the disease by slowing the deterioration of brain function — not just to ease symptoms.

Scott Gottlieb detailed the biggest coordinated enforcement action in the agency’s history to stop sales to minors.

The new information, included in interviews with agency officials and 83 pages of internal documents, might not quiet a furor over the drug Aduhelm that has drawn in Alzheimer’s doctors and patients,...

For the first time, the Food and Drug Administration is weighing whether to allow a daily contraceptive to be sold over the counter.

‘It’s so hurtful that no one is taking a stand’ on a deadly product long targeted at black communities, says health advocate.

The jockeying for the job of FDA commissioner job heated up as patient groups and former agency chiefs endorsed acting head Sharpless as permanent commissioner.

The agency is supposed to decide by Sept. 9 whether the embattled company — and many other e-cigarette manufacturers — will be allowed to keep selling their products and, if so, under what conditions.